Latest Partnerships News

Nanoveu’s subsidiary EMASS has reached a key milestone by moving its ECS-DoT AIoT chip into 16nm synthesis, while unveiling a Modular AIoT Development Kit to accelerate edge intelligence adoption.

FleetPartners has priced a A$400 million asset backed securitisation, featuring a green tranche dedicated to electric vehicle leases, marking a notable step in sustainable finance.

Viridis Mining and Minerals is set to reveal key findings from its Pre-Feasibility Study on the Colossus Rare Earth Element Project, highlighting its global significance and strong economic potential.

Sports Entertainment Group (SEG) is set to become the sole broadcaster of all three Victorian racing codes after agreeing to acquire RSN’s brand and broadcasting assets for $3.25 million.

Australian Agricultural Projects Limited has completed its 2025 olive oil harvest, producing a record 752,600 litres with improved oil quality, despite weather challenges.

DigitalX has raised $20.7 million from leading global digital asset investors to expand its Bitcoin holdings and reinforce its position as a Bitcoin-focused investment manager.

TMK Energy has secured a drilling contract for its LF-07 production well, marking a key milestone in its Lucky Fox Pilot Well Project in Mongolia. The company also outlines an ambitious 2025 exploration program aimed at expanding its coal seam gas resources.

archTIS Limited has successfully raised $7.5 million through a share placement, aiming to fuel its international growth strategy focused on U.S. market expansion, strategic partnerships, and product development.

ClearVue Technologies announces key leadership changes with COO Douglas Hunt stepping in as interim CEO, alongside two new board appointments, signaling a strategic push to accelerate growth and innovation.

Amaero has successfully qualified its C103 and Ti64 metal powders through a collaboration with Auburn University’s NCAME, meeting Velo3D’s standards and paving the way for initial commercial shipments in FY2026.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.